Medline ® Abstract for Reference 112
of 'Chemotherapy for advanced exocrine pancreatic cancer'
A randomized phase 3 study comparing efficacy and safety of gemcitabine and irinotecan to gemcitabine alone in patients with locally advanced or metastatic pancreatic cancer who have not received prior systemic therapy (abstract)
Rocha Lima CM, Rotche R, Jeffery M, et AL
Proc Am Soc Clin Oncol. 2003;22:251a.